Crossref journal-article
Elsevier BV
Trends in Neurosciences (78)
Bibliography

Mata, I. F., Wedemeyer, W. J., Farrer, M. J., Taylor, J. P., & Gallo, K. A. (2006). LRRK2 in Parkinson’s disease: protein domains and functional insights. Trends in Neurosciences, 29(5), 286–293.

Authors 5
  1. Ignacio F. Mata (first)
  2. William J. Wedemeyer (additional)
  3. Matthew J. Farrer (additional)
  4. Julie P. Taylor (additional)
  5. Kathleen A. Gallo (additional)
References 79 Referenced 413
  1. de Rijk, M.C. et al. (2000) Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54 (11, Suppl. 5), S21–S23
  2. 10.1111/j.1749-6632.2003.tb07458.x / Ann. N. Y. Acad. Sci. / Description of Parkinson's disease as a clinical syndrome by Fahn (2003)
  3. 10.1146/annurev.biochem.74.082803.133400 / Annu. Rev. Biochem. / The biochemistry of Parkinson's disease by Cookson (2005)
  4. 10.1146/annurev.neuro.28.061604.135718 / Annu. Rev. Neurosci. / Molecular pathophysiology of Parkinson's disease by Moore (2005)
  5. 10.1016/j.neuron.2004.10.023 / Neuron / Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease by Paisan-Ruiz (2004)
  6. 10.1016/j.neuron.2004.11.005 / Neuron / Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology by Zimprich (2004)
  7. 10.1002/ana.20456 / Ann. Neurol. / Clinical features of LRRK2-associated Parkinson's disease in central Norway by Aasly (2005)
  8. 10.1093/brain/awh666 / Brain / Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease by Berg (2005)
  9. 10.1093/brain/awh667 / Brain / Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data by Khan (2005)
  10. 10.1007/s10048-005-0005-1 / Neurogenetics / Lrrk2 pathogenic substitutions in Parkinson's disease by Mata (2005)
  11. 10.1212/01.WNL.0000169023.51764.b0 / Neurology / LRRK2 mutations in Parkinson disease by Farrer (2005)
  12. 10.1212/01.WNL.0000172630.22804.73 / Neurology / A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations by Zabetian (2005)
  13. 10.1056/NEJMc055540 / N. Engl. J. Med. / LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs by Lesage (2006)
  14. 10.1086/432422 / Am. J. Hum. Genet. / LRRK2 haplotype analyses in European and North African families with Parkinson disease: a common founder for the G mutation dating from the 13th century by Lesage (2005)
  15. 10.1056/NEJMc055509 / N. Engl. J. Med. / LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews by Ozelius (2006)
  16. 10.1016/S0140-6736(05)17829-5 / Lancet / A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease by Di Fonzo (2005)
  17. 10.1086/429256 / Am. J. Hum. Genet. / Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations by Kachergus (2005)
  18. {'key': '10.1016/j.tins.2006.03.006_bib18', 'first-page': '410', 'article-title': "Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease", 'volume': '365', 'author': 'Nichols', 'year': '2005', 'journal-title': 'Lancet'} / Lancet / Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease by Nichols (2005)
  19. {'key': '10.1016/j.tins.2006.03.006_bib19', 'first-page': '415', 'article-title': "A common LRRK2 mutation in idiopathic Parkinson's disease", 'volume': '365', 'author': 'Gilks', 'year': '2005', 'journal-title': 'Lancet'} / Lancet / A common LRRK2 mutation in idiopathic Parkinson's disease by Gilks (2005)
  20. 10.1002/ana.20731 / Ann. Neurol. / Lrrk2 and Lewy body disease by Ross (2006)
  21. 10.1016/S1353-8020(97)00013-8 / Parkinsonism Relat. Disord. / German–Canadian family (Family A) with parkinsonism, amyotrophy, and dementia – longitudinal observations by Wszolek (1997)
  22. 10.1016/j.molmed.2005.12.004 / Trends Mol. Med. / LRRK2: a common pathway for parkinsonism, pathogenesis and prevention? by Taylor (2006)
  23. 10.1016/j.neuroscience.2006.01.017 / Neuroscience / Anatomical localization of leucine-rich repeat kinase 2 in mouse brain by Melrose (2006)
  24. 10.1111/j.1460-9568.2006.04616.x / Eur. J. Neurosci. / LRRK2 is expressed in areas affected by Parkinson's disease in the adult mouse brain by Simon-Sanchez (2006)
  25. 10.1016/j.cellsig.2005.08.015 / Cell. Signal. / LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domain by Korr (2006)
  26. 10.1016/j.bbamcr.2003.08.008 / Biochim. Biophys. Acta / Roc, a Ras/GTPase domain in complex proteins by Bosgraaf (2003)
  27. 10.1126/science.1075762 / Science / The protein kinase complement of the human genome by Manning (2002)
  28. 10.1006/jsbi.2001.4392 / J. Struct. Biol. / Protein repeats: structures, functions, and evolution by Andrade (2001)
  29. 10.1016/S0092-8674(00)80351-7 / Cell / Activation mechanism of the MAP kinase ERK2 by dual phosphorylation by Canagarajah (1997)
  30. 10.1016/S0092-8674(02)00741-9 / Cell / The conformational plasticity of protein kinases by Huse (2002)
  31. 10.1016/j.molcel.2004.08.024 / Mol. Cell / Regulation of protein kinases; controlling activity through activation segment conformation by Nolen (2004)
  32. 10.1016/S0140-6736(05)74809-1 / Lancet / LRRK2 mutations and Parkinsonism by Toft (2005)
  33. 10.1016/S0140-6736(05)74810-8 / Lancet / LRRK2 mutations and Parkinsonism by Albrecht (2005)
  34. 10.1016/j.parkreldis.2005.09.003 / Parkinsonism Relat. Disord. / The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease by Lu (2005)
  35. 10.1073/pnas.0507360102 / Proc. Natl. Acad. Sci. U. S. A. / Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity by West (2005)
  36. 10.1093/hmg/ddi439 / Hum. Mol. Genet. / The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity by Gloeckner (2006)
  37. 10.1016/j.tibs.2005.01.003 / Trends Biochem. Sci. / The RIP kinases: crucial integrators of cellular stress by Meylan (2005)
  38. 10.1016/j.cbpa.2005.04.004 / Curr. Opin. Chem. Biol. / MAPK kinase kinases (MKKKs) as a target class for small-molecule inhibition to modulate signaling networks and gene expression by Johnson (2005)
  39. 10.1126/science.1072682 / Science / Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases by Johnson (2002)
  40. 10.1002/j.1460-2075.1996.tb01007.x / EMBO J. / RIP mediates tumor necrosis factor receptor 1 activation of NF-κB but not Fas/APO-1-initiated apoptosis by Ting (1996)
  41. 10.1038/nrm1498 / Nat. Rev. Mol. Cell Biol. / The RAF proteins take centre stage by Wellbrock (2004)
  42. 10.1038/nrm906 / Nat. Rev. Mol. Cell Biol. / Mixed-lineage kinase control of JNK and p38 MAPK pathways by Gallo (2002)
  43. 10.1146/annurev.pharmtox.44.101802.121840 / Annu. Rev. Pharmacol. Toxicol. / Mixed-lineage kinases: a target for the prevention of neurodegeneration by Wang (2004)
  44. 10.1016/S0003-9861(02)00244-8 / Arch. Biochem. Biophys. / Untying the regulation of the Raf-1 kinase by Dhillon (2002)
  45. 10.1074/jbc.M103496200 / J. Biol. Chem. / Function of the Rho family GTPases in Ras-stimulated Raf activation by Li (2001)
  46. 10.1074/jbc.M502671200 / J. Biol. Chem. / Cdc42 induces activation loop phosphorylation and membrane targeting of mixed lineage kinase 3 by Du (2005)
  47. 10.1074/jbc.273.49.32408 / J. Biol. Chem. / Dimerization via tandem leucine zippers is essential for the activation of the mitogen-activated protein kinase kinase kinase, MLK-3 by Leung (1998)
  48. 10.1074/jbc.M002858200 / J. Biol. Chem. / Zipper-mediated oligomerization of the mixed lineage kinase SPRK/MLK-3 is not required for its activation by the GTPase cdc42 but is necessary for its activation of the JNK pathway by Vacratsis (2000)
  49. Stenmark, H. and Olkkonen, V.M. (2001) The Rab GTPase family. Genome Biol. 2reviews3007.1–reviews3007.7 (10.1186/gb-2001-2-5-reviews3007)
  50. 10.1016/S0962-8924(00)01740-2 / Trends Cell Biol. / Understanding Ras: ‘it ain't over ‘til it's over’ by Shields (2000)
  51. 10.1146/annurev.cellbio.21.020604.150721 / Annu. Rev. Cell Dev. Biol. / Rho GTPases: biochemistry and biology by Jaffe (2005)
  52. 10.1242/jcs.01582 / J. Cell Sci. / Rho signalling at a glance by Schwartz (2004)
  53. 10.1073/pnas.0508052102 / Proc. Natl. Acad. Sci. U. S. A. / Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration by Smith (2005)
  54. 10.1042/EB0410015 / Essays Biochem. / E3 ubiquitin ligases by Ardley (2005)
  55. 10.1038/33416 / Nature / Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism by Kitada (1998)
  56. 10.1016/j.bbamcr.2004.09.026 / Biochim. Biophys. Acta / Ubiquitin, proteasome and parkin by Tanaka (2004)
  57. 10.1126/science.285.5428.751 / Science / Detecting protein function and protein–protein interactions from genome sequences by Marcotte (1999)
  58. 10.1110/ps.03554604 / Protein Sci. / The ankyrin repeat as molecular architecture for protein recognition by Mosavi (2004)
  59. 10.1038/sj.onc.1202918 / Oncogene / Functional evaluation of tumour-specific variants of p16INK4a/CDKN2A: correlation with protein structure information by Ruas (1999)
  60. 10.1038/26155 / Nature / Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a by Russo (1998)
  61. 10.1038/383707a0 / Nature / Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia by Joutel (1996)
  62. 10.1110/ps.03279003 / Protein Sci. / Structure and stability of the ankyrin domain of the Drosophila Notch receptor by Zweifel (2003)
  63. 10.1016/S0959-440X(01)00266-4 / Curr. Opin. Struct. Biol. / The leucine-rich repeat as a protein recognition motif by Kobe (2001)
  64. 10.1212/01.wnl.0000180517.70572.37 / Neurology / Analysis of LRRK2 functional domains in nondominant Parkinson disease by Skipper (2005)
  65. 10.1110/ps.9.12.2470 / Protein Sci. / Thirty-plus functional families from a single motif by Yu (2000)
  66. 10.1038/35107009 / Nature / Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication by Nash (2001)
  67. 10.1146/annurev.biophys.33.110502.133346 / Annu. Rev. Biophys. Biomol. Struct. / The use of in vitro peptide-library screens in the analysis of phosphoserine/threonine-binding domain structure and function by Yaffe (2004)
  68. 10.1016/j.yjmcc.2004.04.019 / J. Mol. Cell. Cardiol. / Interaction of Gβγ with RACK1 and other WD40 repeat proteins by Chen (2004)
  69. 10.1016/S0022-2836(03)00514-X / J. Mol. Biol. / Structural fingerprints of the Ras-GTPase activating proteins neurofibromin and p120GAP by Ahmadian (2003)
  70. 10.1016/S0968-0004(99)01429-2 / Trends Biochem. Sci. / GEFs: structural basis for their activation of small GTP-binding proteins by Cherfils (1999)
  71. 10.1212/01.WNL.0000167552.79769.b3 / Neurology / LRRK2 gene in Parkinson disease by Paisan-Ruiz (2005)
  72. 10.1016/j.neulet.2005.03.033 / Neurosci. Lett. / LRRK2 R1441G in Spanish patients with Parkinson's disease by Mata (2005)
  73. {'key': '10.1016/j.tins.2006.03.006_bib73', 'article-title': "Parkinson's disease and LRRK2: Frequency of a common mutation in U.S. movement disorder clinics", 'author': 'Kay', 'year': '2005', 'journal-title': 'Mov Disord.'} / Mov Disord. / Parkinson's disease and LRRK2: Frequency of a common mutation in U.S. movement disorder clinics by Kay (2005)
  74. 10.1002/ana.20484 / Ann. Neurol. / An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family by Funayama (2005)
  75. 10.1002/mds.20618 / Mov. Disord. / Escaping Parkinson's disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation by Kay (2005)
  76. 10.1093/bioinformatics/btg124 / Bioinformatics / 3D-Jury: a simple approach to improve protein structure predictions by Ginalski (2003)
  77. 10.1093/nar/25.17.3389 / Nucleic Acids Res. / Gapped BLAST and PSI-BLAST: a new generation of protein database search programs by Altschul (1997)
  78. 10.1093/nar/gki418 / Nucleic Acids Res. / FFAS03: a server for profile-profile sequence alignments by Jaroszewski (2005)
  79. 10.1016/0263-7855(96)00009-4 / J. Mol. Graph. / MOLMOL: a program for display and analysis of macromolecular structures by Koradi (1996)
Dates
Type When
Created 19 years, 4 months ago (April 18, 2006, 3:18 p.m.)
Deposited 4 years, 1 month ago (July 25, 2021, 2:45 p.m.)
Indexed 1 week, 2 days ago (Aug. 27, 2025, 11:58 a.m.)
Issued 19 years, 4 months ago (May 1, 2006)
Published 19 years, 4 months ago (May 1, 2006)
Published Print 19 years, 4 months ago (May 1, 2006)
Funders 0

None

@article{Mata_2006, title={LRRK2 in Parkinson’s disease: protein domains and functional insights}, volume={29}, ISSN={0166-2236}, url={http://dx.doi.org/10.1016/j.tins.2006.03.006}, DOI={10.1016/j.tins.2006.03.006}, number={5}, journal={Trends in Neurosciences}, publisher={Elsevier BV}, author={Mata, Ignacio F. and Wedemeyer, William J. and Farrer, Matthew J. and Taylor, Julie P. and Gallo, Kathleen A.}, year={2006}, month=may, pages={286–293} }